Editas Medicine (EDIT) Change in Receivables (2015 - 2025)
Editas Medicine (EDIT) reported Change in Receivables of $7.5 million for Q3 2025, up 6491.53% year-over-year from $114419.6 in Q3 2024, and up 9569.23% on a QoQ basis from $78000.0 in Q2 2025.
Editas Medicine (EDIT) has 11 years of Change in Receivables data on file, last reported at $7.5 million in Q3 2025.
- Quarterly Change in Receivables rose 6491.53% year-over-year to $7.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8.0 million (up 448.61% YoY) and the FY2024 annual result came in at $6.1 million, up 20.57% from the prior year.
- Change in Receivables rose to $7.5 million in Q3 2025 per EDIT's latest filing, from $78000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $16.1 million in Q4 2024 and bottomed at -$15.8 million in Q1 2025.
- The 5-year median for Change in Receivables is -$1000.0 (2024), against an average of $109578.9.
- The widest annual swing landed in 2021, when Change in Receivables tumbled 1133.33%; it then soared 31306.25% in 2022.
- Tracing EDIT's Change in Receivables over 5 years: stood at $16000.0 in 2021, then soared by 31306.25% to $5.0 million in 2022, then soared by 54.53% to $7.8 million in 2023, then surged by 107.86% to $16.1 million in 2024, then tumbled by 53.27% to $7.5 million in 2025.
- Per Business Quant, the three latest EDIT Change in Receivables figures stand at $7.5 million (Q3 2025), $78000.0 (Q2 2025), and -$15.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.54 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | -15.76 Mn |
| Mar 31, 2025 | -15.76 Mn |
| Dec 31, 2024 | 16.14 Mn |
| Dec 31, 2024 | 16.14 Mn |
| Sep 30, 2024 | -118,000.00 |
| Sep 30, 2024 | -118,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -9.94 Mn |
| Mar 31, 2024 | -9.94 Mn |
| Dec 31, 2023 | 7.77 Mn |
| Dec 31, 2023 | 7.77 Mn |
| Sep 30, 2023 | 136,000.00 |
| Sep 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Dec 31, 2022 | 5.03 Mn |
| Dec 31, 2022 | 5.03 Mn |
| Sep 30, 2022 | -593,000.00 |
| Sep 30, 2022 | -593,000.00 |
| Jun 30, 2022 | -659,000.00 |
| Jun 30, 2022 | -659,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 16,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | -80,000.00 |
| Sep 30, 2021 | -80,000.00 |
| Jun 30, 2021 | -341,000.00 |
| Jun 30, 2021 | -341,000.00 |
| Mar 31, 2021 | -5.38 Mn |
| Mar 31, 2021 | -5.38 Mn |
| Dec 31, 2020 | 4.99 Mn |
| Dec 31, 2020 | 4.99 Mn |
| Sep 30, 2020 | -810,000.00 |
| Sep 30, 2020 | -810,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Mar 31, 2020 | 1.41 Mn |
| Mar 31, 2020 | 1.41 Mn |
| Dec 31, 2019 | 107,000.00 |
| Dec 31, 2019 | 107,000.00 |
| Sep 30, 2019 | 299,000.00 |
| Sep 30, 2019 | 299,000.00 |
| Jun 30, 2019 | 12,000.00 |
| Jun 30, 2019 | 12,000.00 |
| Mar 31, 2019 | -30,000.00 |
| Mar 31, 2019 | -30,000.00 |
| Dec 31, 2018 | -13,000.00 |
| Dec 31, 2018 | -13,000.00 |
| Sep 30, 2018 | -319,000.00 |
| Sep 30, 2018 | -319,000.00 |
| Jun 30, 2018 | -569,000.00 |
| Jun 30, 2018 | -569,000.00 |
| Mar 31, 2018 | 252,000.00 |
| Mar 31, 2018 | 252,000.00 |
| Sep 30, 2017 | 607,000.00 |
| Sep 30, 2017 | 607,000.00 |
| Jun 30, 2017 | 732,000.00 |
| Jun 30, 2017 | 732,000.00 |
| Mar 31, 2017 | 857,000.00 |
| Mar 31, 2017 | 857,000.00 |
| Dec 31, 2016 | -1.03 Mn |
| Dec 31, 2016 | -1.03 Mn |
| Sep 30, 2016 | -73,000.00 |
| Sep 30, 2016 | -73,000.00 |
| Jun 30, 2016 | 87,000.00 |
| Jun 30, 2016 | 87,000.00 |
| Mar 31, 2016 | 89,000.00 |
| Mar 31, 2016 | 89,000.00 |
| Dec 31, 2015 | 2.06 Mn |
| Dec 31, 2015 | 2.06 Mn |
| Sep 30, 2015 | -840,000.00 |
| Sep 30, 2015 | -840,000.00 |